| Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers S Ballal, MP Yadav, ES Moon, VS Kramer, F Roesch, S Kumari, M Tripathi, ... European journal of nuclear medicine and molecular imaging 48, 1915-1931, 2021 | 116 | 2021 |
| A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new … S Ballal, MP Yadav, V Kramer, ES Moon, F Roesch, M Tripathi, S Mallick, ... European journal of nuclear medicine and molecular imaging 48, 942-944, 2021 | 112 | 2021 |
| 177Lu-/68Ga-PSMA theranostics in recurrent glioblastoma multiforme: proof of concept A Kumar, S Ballal, MP Yadav, ST ArunRaj, KP Haresh, S Gupta, ... Clinical nuclear medicine 45 (12), e512-e513, 2020 | 42 | 2020 |
| Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo A Kumar, ST ArunRaj, K Bhullar, KP Haresh, S Gupta, S Ballal, M Yadav, ... Neuroradiology, 1-11, 2022 | 22 | 2022 |
| First-in-human experience with 177Lu-DOTAGA.(SA. FAPi) 2 therapy in an uncommon case of aggressive medullary thyroid carcinoma clinically mimicking as anaplastic thyroid cancer S Ballal, MP Yadav, ES Moon, F Rösch, ST ArunRaj, S Agarwal, ... Clinical Nuclear Medicine 47 (6), e444-e445, 2022 | 20 | 2022 |
| Incremental value of single-photon emission computed tomography/computed tomography in the diagnosis of active condylar hyperplasia KK Agarwal, A Mukherjee, ST ArunRaj, M Tripathi, C Bal Nuclear Medicine Communications 38 (1), 29-34, 2017 | 14 | 2017 |
| Comparison of prostate-specific membrane antigen PET/CT and contrast-enhanced magnetic resonance imaging in follow-up assessment of juvenile nasal angiofibroma—a novel pilot study A Thakar, P Sakthivel, ST Arunraj, AS Bhalla, A Kakkar, R Kumar Clinical Nuclear Medicine 45 (12), e498-e504, 2020 | 13 | 2020 |
| Fusion 68Ga–prostate-specific membrane antigen PET/MRI on postoperative surveillance of juvenile nasal angiofibroma P Sakthivel, A Thakar, ST Arunraj, AS Bhalla, R Kumar Clinical nuclear medicine 45 (7), e325-e326, 2020 | 12 | 2020 |
| Prostate-specific membrane antigen imaging in recurrent medullary thyroid cancer: a new theranostic tracer in the offing? S Arora, M Prabhu, NA Damle, C Bal, P Kumar, H Nalla, STA Raj Indian Journal of Nuclear Medicine 33 (3), 261-263, 2018 | 12 | 2018 |
| 68ga-dotanoc Pet/Ct in medulloblastoma ST Arunraj, GK Parida, NA Damle, S Arora, S Reddy, D Chakraborty, ... Clinical Nuclear Medicine 43 (5), e145-e146, 2018 | 12 | 2018 |
| Clinical implications of tubarial salivary glands A Thakar, R Kumar, AS Thankaraj, M Rajeshwari, P Sakthivel Radiotherapy and Oncology 154, 319-320, 2021 | 10 | 2021 |
| An Unusual Case of Simultaneous Cricoid and Thyroid Cartilage Metastases from Prostatic Adenocarcinoma on 68Ga-PSMA PET/CT A Tupalli, NA Damle, ARS Thankarajan, BS Mangu, A Kumar, D Khan, ... Nuclear Medicine and Molecular Imaging 54, 61-62, 2020 | 8 | 2020 |
| Validation of postoperative angiofibroma radionuclide imaging study (PARIS) protocol using PSMA PET/CT—a proof of concept study A Thakar, P Sakthivel, ST Arunraj, AS Bhalla, A Prashanth, R Kumar, ... Clinical Nuclear Medicine 46 (5), e242-e249, 2021 | 7 | 2021 |
| A rare presentation of Erdheim Chester disease in a pediatric patient subsequently cured on the LCH III protocol AK Gupta, JP Meena, ST ArunRaj, A Mridha, P Naranje, R Kumar, R Seth Cancer Reports 4 (1), e1304, 2021 | 6 | 2021 |
| Unusual presentation of rare cardiac tumor: the role of F-18-Fluorodeoxyglucose positron emission tomography/computed tomography SK Taywade, NA Damle, M Tripathi, ST ArunRaj, A Passah, AS Malhi, ... Indian Journal of Nuclear Medicine 32 (2), 157-158, 2017 | 6 | 2017 |
| Role of 18-fluorodeoxyglucose positron emission tomography-computed tomography in predicting residual disease posttreatment completion in retinoblastoma patients AW Moothedath, KK Chopra, R Seth, JP Meena, AK Gupta, R Kumar, ... Indian Journal of Nuclear Medicine 37 (2), 142-146, 2022 | 5 | 2022 |
| Physiological PSMA uptake in the tubarial salivary glands and its implications in the PARIS protocol—A first study of its kind! P Sakthivel, A Thakar, ST Arunraj, A Prashanth, R Kumar, SC Sharma Clinical Nuclear Medicine 46 (8), e398-e405, 2021 | 5 | 2021 |
| Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report A Thakar, P Sakthivel, ST Arunraj, AS Bhalla, A Prashanth, R Kumar, ... Nuclear Medicine Communications 42 (5), 517-522, 2021 | 5 | 2021 |
| Advantage of 68Ga-PSMA PET/CT on postradiotherapy response assessment of juvenile nasal angiofibroma P Sakthivel, A Thakar, ST Arunraj, AS Bhalla, R Kumar Clinical Nuclear Medicine 46 (2), e123-e124, 2021 | 5 | 2021 |
| Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma S Verma, SP Vadlamani, SA Shamim, A Barwad, S Rastogi, STA Raj Clinical Sarcoma Research 10, 1-6, 2020 | 5 | 2020 |
